Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Operating Income (2020 - 2025)

Celularity (CELU) has disclosed Operating Income for 6 consecutive years, with -$12.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Income fell 11.91% to -$12.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$48.5 million, a 207.87% decrease, with the full-year FY2024 number at -$38.4 million, up 80.05% from a year prior.
  • Operating Income was -$12.9 million for Q3 2025 at Celularity, up from -$15.9 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $17.5 million in Q4 2022 to a low of -$99.3 million in Q3 2023.
  • A 5-year average of -$21.3 million and a median of -$11.5 million in 2024 define the central range for Operating Income.
  • Biggest YoY gain for Operating Income was 326.76% in 2021; the steepest drop was 29007.3% in 2021.
  • Celularity's Operating Income stood at -$15.0 million in 2021, then skyrocketed by 216.95% to $17.5 million in 2022, then fell by 23.85% to $13.3 million in 2023, then plummeted by 169.7% to -$9.3 million in 2024, then plummeted by 39.01% to -$12.9 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Operating Income are -$12.9 million (Q3 2025), -$15.9 million (Q2 2025), and -$10.5 million (Q1 2025).